Ralf Ludwig: When a Promising Biomarker Falls Short
Ralf Ludwig, Director of the Lübeck Institute of Experimental Dermatology at the University of Lübeck, shared a post on LinkedIn about a recent article by Ahmad Alsaber et al., published in Frontiers in Medicine, adding:
“A paper that went looking for a biomarker, found nothing, and got published on the strength of how well it looked.
That’s how it should work.
The third paper in our Research Topic is a null result – and it earns its place precisely because it is one.
The hypothesis was reasonable: in rheumatoid arthritis, inflammation reshapes lipid metabolism, so perhaps the triglyceride-to-HDL ratio could serve as a cheap surrogate for disease activity.
Tidy idea.
Using 1,212 adults from the Kuwait Registry for Rheumatic Diseases – a Gulf population where this question is barely studied – the authors tested it properly.
It didn’t hold.
TG/HDL showed no independent association with disease activity (DAS28).
Nor did LDL, HDL, or triglycerides alone.
The finding survived every stress test the authors threw at it: a higher activity threshold, continuous scoring, expanded confounder adjustment, subgroups by sex and obesity.
Reliably, robustly null.
Which is the point.
A convenient surrogate that doesn’t work is worth knowing before someone builds a clinic pathway on it – and the authors are admirably plain about their own limitations.
Negative findings from under-represented populations are exactly the kind of honest science that tends to die in a file drawer.
This one didn’t.
Paper 3 of seven now published in the collection.
Congratulations to Ahmad Alsaber and colleagues …!
Submit your study․”
Title: Lipid parameters and disease activity in rheumatoid arthritis: a cross-sectional analysis of the Kuwait registry for rheumatic diseases (KRRD)
Authors: Fatima Ali, Ghaydaa Aldabie, Ahmad Alsaber
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 14:07Chokri Ben Lamine: Pain After Allogeneic Stem Cell Transplantation in Sickle Cell Disease
-
Oct 9, 2026, 13:55Chandler Purser: AABB 2026 Focuses on Transfusion Safety and Audit-Driven Practice Improvement
-
Oct 9, 2026, 13:48Maxime Dely: Raising Awareness for Blood Donation
-
Oct 9, 2026, 13:48Vera Ghali: Anemia in Myelofibrosis and Its Impact on Treatment Outcomes and Overall Survival
-
Oct 9, 2026, 13:32W David Freeman։ The Mechanical Penumbra in Intracerebral Hemorrhage and Its Potential for Tissue Recovery
-
Oct 9, 2026, 13:11Ayshathul Noora։ Carbetocin vs Oxytocin in Preventing Postpartum Hemorrhage
-
Oct 9, 2026, 13:07The Rebalanced Patient: New Therapies and New Thrombotic Risks in Hemophilia
-
Oct 9, 2026, 12:48Santiago Cepeda Chafla: CereBleed Simplifies Brain Hemorrhage Assessment
-
Oct 9, 2026, 12:34Abdul Muqtadir Abbasi: Pancytopenia Is a Finding, Not a Diagnosis